Related Interviews

Opportunities in Regenerative Medicine, Cancer Immunotherapy Markets for Value Investors
July 06, 2015
Jason Kolbert

Handpicked Stocks in Emerging Pharmaceuticals
November 24, 2014
Moussatos, Liana

Managing a Growth Portfolio with a Focus on Company-Specific Metrics
September 08, 2014
Sansoterra, Michael A.

Seeking Growth at a Reasonable Price While Considering Secular Themes
May 02, 2014
Wehner, Diane M.

Biotechnology Capital Inflows Reach Historic Highs
April 07, 2014
Skorney, Brian

Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013
Tenthoff, Ted

FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market
April 08, 2013
Skorney, Brian

Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013
Ferreiro, David

Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012
Roden, Matthew

Defensive Plays In The Defense Space - Michael F. Ciarmoli - Keybanc Capital Markets Inc.
November 14, 2011
Ciarmoli, Michael F.

"common Sense" Investment Management - Kendall J. Anderson - Anderson Griggs Portfolio Management
November 14, 2011
Anderson, Kendall J.

Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011
Kantor, Jason

Health Care Services & Tech Outlook - Ross Muken - Deutsche Bank Securities, Inc.
November 15, 2010
Muken, Ross

Overview Of Midwestern Regional Bank Metrics - Craig Siegenthaler - Credit Suisse
April 05, 2010
Siegenthaler, Craig

Update On Science Tools & Diagnostics - Isaac Ro - Leerink Swann & Company
January 25, 2010
Ro, Isaac

Investing In Regulated Electric Utilities - Marc De Croisset - Macquarie Capital (usa) Inc.
May 18, 2009
De Croisset, Marc

Sector-focused Growth Management - Frank Mastrapasqua & Mauro M. Mastrapasqua - Mastrapasqua Asset Management
June 09, 2008

K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005

KEVIN CAREY - 1ST SOURCE CORPORATION INVESTMENT ADVISORS INC
July 19, 2004
Carey, Kevin A.

JONATHAN ROTHBERG - CURAGEN CORPORATION (CRGN)
March 08, 2004
Rothberg, Jonathan M.

L.holtz / Y.lipsker - Roger Engemann & Associates
July 28, 2003
Lipsker, Yossi, Holtz, Lou

Large Cap Biotechnology & Life Sciences: Ronald Renaud - Bear, Stearns & Co
September 13, 2002
Renaud, Ronald C.

Wayne Yetter - Synavant Inc (snvt)
September 13, 2002
Yetter, Wayne

Ian Smith - Vertex Pharmaceuticals Inc (vrtx)
June 02, 2002
Smith, Ian F.

R.schwarzkopf / S.gleason - Kayne Anderson Rudnick Investment Mgmt Llc
February 25, 2002
Gleason, Sandi L., Schwarzkopf, Robert A.

George Robson - Dendrite International (drte)
September 14, 2001
Robson, George

Japanese Semiconductor Companies & Electronics: Scott Foster - Lehman Brothers
September 12, 2001
Foster, Scott

Mary Ann Gray - Federated Kaufmann Fund
June 07, 2001
Gray, Mary Ann

Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001
Frevert, Mark A.

Outlook For Biotechnology Stocks: William Slattery - Deerfield Management
December 18, 2000
Slattery, William

D.altabef / D.katz - Matrix Asset Advisors
December 18, 2000
Altabef, Douglas S., Katz, David A.

George Kellner - Kellner, Dileo & Co
November 20, 2000
Kellner, George A.

Emerging Pharamaceutical Companies : Corey Davis - Chase H&q
January 13, 2000
Davis, Corey

Joe C. Cook Jr. - Amylin Pharmaceuticals (amln)
January 13, 2000
Cook, Joe C.

Ian Prosser - Bass Plc (bass.l)
January 03, 2000
Prosser, Sir Ian

Roundtable Forum: Major Chemicals
December 20, 1999
Semegran, Theodore (Ted) S., Leming, Paul T., Roberts, John E., Mitsch, Frank J.

Biotherapeutics Stocks : Michael G. King Jr. - Robertson Stephens
December 06, 1999
King, Michael G.

Pin It on Pinterest

Share This